Get started
Apellis Pharmaceuticals, Inc. 3.5% 15-SEP-2026Apellis Pharmaceuticals, Inc. 3.5% 15-SEP-2026Apellis Pharmaceuticals, Inc. 3.5% 15-SEP-2026

Apellis Pharmaceuticals, Inc. 3.5% 15-SEP-2026

No trades
See on Supercharts
Overview
Analysis News

APLS5052553 chart


Full chart

Key terms


Outstanding amount
‪93.90 M‬ USD
Face value
1,000.00 USD
Minimum denomination
1,000.00 USD
Coupon
3.50% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
−3.02%
Maturity date
Sep 15, 2026
Term to maturity
1 year

About Apellis Pharmaceuticals, Inc. 3.5% 15-SEP-2026


Issuer
Apellis Pharmaceuticals, Inc.
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
apellis.com
Issue date
Sep 24, 2020
FIGI
BBG00Q7B2LY4
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

APLS5052553 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

APLS5052553 news



Dive into corporate with bonds that match in maturity and industry.